Asunaprevir is an HCV NS3/4A protease inhibitor used in combination with other antiviral agents to treat chronic hepatitis C virus infection. This direct-acting antiviral functions by inhibiting the cleavage… Read more
Asunaprevir is an HCV NS3/4A protease inhibitor used in combination with other antiviral agents to treat chronic hepatitis C virus infection. This direct-acting antiviral functions by inhibiting the cleavage of the viral polyprotein, which effectively blocks viral replication and facilitates the clearance of the virus from the bloodstream. To support the rigorous analytical requirements of pharmaceutical development and manufacturing, this category includes high-quality impurities, metabolites, and stable isotope labelled standards for the active pharmaceutical ingredient. These reference standards are essential tools for impurity profiling, method validation, and ongoing quality control, ensuring that analytical testing procedures remain precise and accurate throughout the drug development lifecycle. Laboratories rely on these related compounds to identify unknown peaks, quantify degradation products, and confirm the structural integrity of Asunaprevir in complex matrices.